{"id":"W4402929046","doi":"10.1002/cpt.3445","title":"A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Genentech; Roche","keywords":"Medicine; Regimen; Follicular lymphoma; Neutropenia; Dosing; Internal medicine; Adverse effect; Refractory (planetary science); Population; Pharmacokinetics; Oncology; Lymphoma; Gastroenterology; Pharmacology; Toxicity; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003799853,0.0002297335,0.0004223941,0.0003115542,0.00006721795,0.0003550178,0.0003774303,0.0003034987,0.001359901],"category_scores_gemma":[0.0009235757,0.0001311603,0.0003000388,0.0001492984,0.0001242799,0.0002444844,0.0002182627,0.0006524001,0.0001828146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003504309,"about_ca_system_score_gemma":0.0002640756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004358877,"about_ca_topic_score_gemma":0.00079068,"domain_scores_codex":[0.9997782,0.00008057011,0.00001322463,0.00004316393,0.00005632141,0.0000284375],"domain_scores_gemma":[0.9998459,0.0000596561,0.00004723405,0.00001562294,0.00001060607,0.0000209737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02008846,0.006514977,0.008266068,0.0003510044,0.000539894,0.0002575943,0.0001891211,0.04729109,0.2865325,0.002394918,0.002371988,0.6252023],"study_design_scores_gemma":[0.02070689,0.1826151,0.09551319,0.000191044,0.002542904,0.001913043,0.0001700041,0.4487567,0.2147643,0.004682657,0.02788427,0.0002598912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861247,0.001444622,0.01004002,0.0001611076,0.00002489713,0.0002717889,0.0001420461,0.0001826548,0.001608211],"genre_scores_gemma":[0.995555,0.0002400453,0.003669864,0.00006016135,0.00001103202,0.00007578882,0.00007174768,0.000009420039,0.0003069058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001359901,"threshold_uncertainty_score":0.004549325,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028783155907505,"score_gpt":0.4523550682450669,"score_spread":0.3494767526543164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}